REMEDY : BNSSG referral pathways & Joint Formulary

BNSSG Paediatric Joint Formulary
Home > Formulary : Paediatric > Recent Decisions > 2024 >

Decisions 10th December

The following decisions were made at the Joint Formulary Group meeting held on Tuesday 10th December:

New Drug Requests

Rivaroxaban for venous thrombosis (TLS Red)

Rivaroxaban for primary thromboprophylaxis in children post fontan completion (TLS Red)

Semaglutide (Wegovy) for severe obesity in children (TLS Red) 

  • Approved from a clinical perspective, additional work and evaluation are needed before it can be included on the Formulary. As of now, it remains non-formulary

 

Other discussions/decisions

Paediatric palliative care chapter review completed